Share Name Share Symbol Market Type Share ISIN Share Description
Ideagen LSE:IDEA London Ordinary Share GB00B0CM0C50 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  +1.00p +0.72% 140.00p 7,275,296 16:35:19
Bid Price Offer Price High Price Low Price Open Price
140.00p 142.00p 143.50p 139.00p 139.00p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Software & Computer Services 36.12 1.40 0.77 181.8 306.9

Ideagen (IDEA) Latest News

More Ideagen News
Ideagen Takeover Rumours

Ideagen (IDEA) Share Charts

1 Year Ideagen Chart

1 Year Ideagen Chart

1 Month Ideagen Chart

1 Month Ideagen Chart

Intraday Ideagen Chart

Intraday Ideagen Chart

Ideagen (IDEA) Discussions and Chat

Ideagen (IDEA) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Ideagen trades in real-time

Ideagen (IDEA) Top Chat Posts

DateSubject
18/11/2018
08:20
Ideagen Daily Update: Ideagen is listed in the Software & Computer Services sector of the London Stock Exchange with ticker IDEA. The last closing price for Ideagen was 139p.
Ideagen has a 4 week average price of 137.50p and a 12 week average price of 136.50p.
The 1 year high share price is 174p while the 1 year low share price is currently 87.50p.
There are currently 219,224,013 shares in issue and the average daily traded volume is 212,198 shares. The market capitalisation of Ideagen is £306,913,618.20.
05/10/2018
20:17
garbetklb: Hi Rivaldo Sorry - my post wasn't clear. RNS 23/03/17 announcing the 2017 LTIP awarded Spenceley / Dorks / Kent 1,200,000 options each at 1p. At today's share price of circa 150p, that's circa £5.4m - yes, I accept that it wasn't worth that at the time of the award, but it's a lot of money - excessive, in my view. I see your interpretation re your 3rd point; not sure I agree. Looking at the (presumably summary) of the LTIP conditions, in order for the full award to be made the share price has to exceed 136p for 30 consecutive business days - from a quick glance, I suspect that has been achieved just now. What happens if the price subsequently drops isn't spelt out in the 23/03/17 RNS. IF it says that the share price has to exceed 136p for THE 30 days prior to exercising the option, I reckon today's announcement could be in the "bird in the hand" category for 50% of the award. Regardless, I'm not keen on such levels of remuneration, especially relative to profits. Others may be more relaxed, given growth etc. That's why we don't all buy the same shares! Good luck to all holders.
05/10/2018
11:26
rivaldo: As regards Garbetklb's post, firstly a total of 1.8m shares have been issued, i.e at the current price around £2.7m (no idea where his £5.2m comes from). Secondly, only one director fully sold their resulting shares. The other two have only sold 50% of their additional shares - enough only to cover costs and income tax payable (which would of course be taxed at the higher rate of 40%). Thirdly, the early exercise of the LTIP shares - without a full resultant sale - is a GOOD sign. This is usually done because the people exercising wish to minimise their tax liability by exercising early rather than waiting, since they presumably believe that by waiting the share price will rise sufficiently such that they would have a much higher income tax liability.
21/9/2018
10:25
speedsgh: 'Kiss of IC' ;-) Share price taking a well-earned breather. It is nearly the weekend after all.
13/9/2018
22:01
breeze3337: A 7% dilution. Will the share price reflect this on placement of the new shares?
13/9/2018
10:53
rivaldo: Great news - a quick £20m placing at 142p to fund a variety of acquisitions which are already identified and should be completed within weeks. Only recently we'd have been over the moon at raising money at 142p, so no complaints here, and the discount to the current share price is really pretty tiny. And note the para on current trading: Https://www.investegate.co.uk/ideagen-plc--idea-/rns/proposed-placing-to-raise--20-million/201809131130017085A/ "Current Trading and Outlook Trading remains robust and in line with management expectations. The Company is seeing strong demand for its products from new customers and the Board are pleased to see further growth in its recurring revenues."
13/9/2018
08:17
rivaldo: Shares Magazine today features IDEA as one of their Great Idea updates, and conclude: "A now largely proven quality business, investors should stick with the stock for further share price upside." Interestingly, they also say: "remember, management have their own 200p internal share price target, and we would not bet against such optimism."
18/5/2018
05:54
rivaldo: That's an interesting article in Shares Magazine, disclosing the internal 200p share price target and noting that current forecasts could be beaten "by a wide margin". Other useful snippets: GRC "is a $7bn-a-year GRC market yet it remains highly fragmented. Ideagen, which has been around since 1993, wants to act as an industry consolidator as well as driving consistent organic growth." "It aims to double revenue and profit every three years and has met or beaten those targets in the past. For example, in 2015 it reported revenue of £14.4m and £3.6m pre-tax profit. The year to 30 April 2018 is expected to show £36.1m of sales and £9.7m of pre-tax profit. Throughout this growth the company has remained highly cash generative and paid modest dividends. The US is now its number one growth market, as it is the world’s single biggest place for GRC spending. That means accelerating acquisitions growth, such as April’s $8.7m purchase of Medforce, a healthcare compliance business." "The net of regulation red tape and compliance accountability is getting ever tighter around industries and organisations across the world. The next big one is EUwide General Data Protection Regulation (GDPR) which comes into force on 25 May and is the latest in a long list of rules designed to keep us better protected. All this puts UK software supplier Ideagen (IDEA:AIM) in a sweet spot thanks to its wide range of off-the-shelf specialised tools. The Midlands-based company concentrates on what it calls the governance, risk and compliance (GRC) space, providing information management solutions to highly regulated industries. Think healthcare, aviation, banking/finance, complex manufacturing, defence and energy."
29/1/2018
11:49
davidosh: Just a reminder that Ideagen will have a stand and be presenting at our huge Mello2018 event in Derby on 26/27th April and all shareholders and potential investors are welcome to attend Http://mello2018.com/index.html IDEA attended and presented at our Mello2014 & Mello2015 events and the share price was only 33p at the first one so it really is beneficial to attend and meet these growth companies to hopefully spot the very good ones as opposed to just good ones.... Do come and join us at this quality two day event.
28/1/2018
11:44
rivaldo: The article itself says the Mail first tipped IDEA when the share price was 33p. So it's more than tripled since then, which is hardly "featuring a share after its bolted". Much share tipstering is indeed helping out mates, jumping on bandwagons etc. But not all. The Mail is due at least a little credit in this instance :o)) "Clever ideas like this have helped Ideagen to more than triple in size since Midas first recommended the firm in 2014. Then, shares were 33p, turnover was £9 million and profit was £2.6 million."
29/12/2016
11:26
pj 1: Here you go Rivaldo, I think a week is safe enough time to leave before posting to be fair to other subscribers. Ideagen (IDEA:AIM) Share price: 64.25p Market cap: £117m EPS Apr 2017: 3.2 PE Apr 2017: 20 Dividend Apr 2017: 0.2p Dividend yield: 0.3% Source: Shares, FinnCap Life sciences 3 There’s a net of rules, regulations and red tape tightening over many industries. Little UK software supplier Ideagen (IDEA:AIM) has a wide range of off-the-shelf specialised software tools smack bang in this, albeit unglamorous, sweet spot. The Midlands-based company concentrates on what it calls the governance, risk and compliance (GRC) space, providing information management solutions to highly regulated industries. Target markets include healthcare, complex manufacturing, banking/finance, defence and energy. Ideagen supplies an integrated system that combines information from multiple operational sources on top of the typical internal audit and compliance functions. This provides clients with a detailed overview of corporate risk, controls and consequence mitigation analysis. That’s an increasingly compelling sale once an organisation begins to grasp the significant financial and reputational damage potential of not having adequate systems in place. Cover IDEAGEN 221216 Loyal fans We’ve been fans of the company since it gravitated to AIM from the old Plus Markets in 2012, first flagging the investment opportunity at 16p in August that year. The company hasn’t put a foot wrong ever since; adding carefully vetted bolt-on acquisitions to its underlying progress. Three acquisitions have been made since summer 2016 alone, being Covalent, Logen and IPI Solutions. Full year results to 30 April 2016 revealed a 52% revenue jump to £21.9 million including respectable 10% organic growth. That led to a 57% leap in adjusted EBITDA (earnings before interest, tax, depreciation and amortisation) to £6.3 million and improved operating cash conversion metrics. Shareholders should feel rightly chuffed about a 96% client renewals hit rate and 100 new customers won during that year. Ideagen also won its biggest single contract ever, worth £4.9 million. We believe the scale of new business is also improving. Healthy and wealthy A trading update in November implies the business is still in excellent health. We’ll find out more when half year results are published in January. FinnCap forecasts pre-tax profit rising by 21% to £6.9m for the full year to April 2017 – and then advancing to £8.4m a year later. It is also worth noting that Ideagen could potentially benefit from Brexit as that will increase red tape. Companies will need to comply with existing EU and international standards as well as the potential for the implementation of UK standards. (SF)
Ideagen share price data is direct from the London Stock Exchange
add chat code
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V: D:20181119 03:41:38